Yabao Pharmaceutical Group Co., Ltd (600351.SS) SHH

6.75

-0.12(-1.75%)

Updated at October 20 09:25AM

Currency In CNY

Valuation

Market Cap4.35B
Enterprise Value3.86B
P/E Ratio20.05
PEG Ratio0.2
Price/Sales Ratio1.98
Price/Book Ratio1.7
Enterprise/Revenue1.77
Enterprise/EBITDA14.34

Fiscal Year

Fiscal YearDecember 31, 2024
Most Recent QuarterJune 30, 2025

Profitability

Profit Margin0.1
Operating Margin0.13

Management Effectiveness

Return On Assets0.07
Return On Equity0.08

Income Statement

Revenue2.69B
Revenue/Share3.38
Gross Profit1.39B
EBITDA437.96M
Net Income242.69M
Diluted EPS0.34

Balance Sheet

Total Cash656.03M
Total Cash/Share0.93
Total Debt141.38M
Total Debt/Equity0.05
Current Ratio2.82
Book Value Per Share3.98

Price History

52-Week Change13.83
52-Week High8.68
52-Week Low5.35
Moving Average 50 Days6.92
Moving Average 200 Days6.4

Statistics

Average Volume40.2M
Shares Outstanding700M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate0.3
Trailing Annual Dividend Yield4.44
Payout Ratio0.89
Last Split Factor2:1
Last Split DateMay 28, 2010